These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 23957970

  • 1. Acne masquerading as malignant melanoma on positron emission tomography-computed tomography scan.
    Atanasovski M, Watson AC.
    J Am Acad Dermatol; 2013 Sep; 69(3):480. PubMed ID: 23957970
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Positron emission tomography/computed tomography in melanoma.
    Bourgeois AC, Chang TT, Fish LM, Bradley YC.
    Radiol Clin North Am; 2013 Sep; 51(5):865-79. PubMed ID: 24010910
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
    Jung JY, Roh MR, Chung HJ, Chung KY.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):126-7. PubMed ID: 18181996
    [No Abstract] [Full Text] [Related]

  • 6. Whole-body positron emission tomography: an accurate staging modality for metastatic melanoma.
    Böni R.
    Arch Dermatol; 1996 Jul; 132(7):833-4. PubMed ID: 8678582
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Melanoma imaging with highly specific PET probes: ready for prime time?
    Minn H, Vihinen P.
    J Nucl Med; 2011 Jan; 52(1):5-7. PubMed ID: 21149485
    [No Abstract] [Full Text] [Related]

  • 9. Fluorodeoxyglucose positron emission tomography for melanoma staging: refining the indications.
    Wagner JD.
    Ann Surg Oncol; 2006 Apr; 13(4):444-6. PubMed ID: 16491336
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Gastrointestinal metastasis of malignant melanoma].
    Hackländer T, Schulte KW, Jungblut RM.
    Aktuelle Radiol; 1996 May; 6(3):156-8. PubMed ID: 8679741
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T, Meyer N, Zerdoud S, Julian A, Chevreau C, Payoux P, Courbon F.
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [Abstract] [Full Text] [Related]

  • 15. The use of computed body tomography in malignant melanoma.
    Kostrubiak I, Whitley NO, Aisner J, Goose P, DeLuca RR, Didolkar MS, Elias EG.
    JAMA; 1988 May 20; 259(19):2896-7. PubMed ID: 3367457
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
    Abbott RA, Acland KM, Harries M, O'Doherty M.
    Melanoma Res; 2011 Oct 20; 21(5):446-9. PubMed ID: 21849913
    [Abstract] [Full Text] [Related]

  • 19. Baseline staging of melanoma with unknown primary site: the value of serum s100 protein and positron emission tomography.
    Oberholzer PA, Urosevic M, Steinert HC, Dummer R.
    Dermatology; 2008 Oct 20; 217(4):351-5. PubMed ID: 18799883
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.